EP0403626B1 - Storage and transfer bottle designed for storing two components of a medicamental substance - Google Patents
Storage and transfer bottle designed for storing two components of a medicamental substance Download PDFInfo
- Publication number
- EP0403626B1 EP0403626B1 EP19900900743 EP90900743A EP0403626B1 EP 0403626 B1 EP0403626 B1 EP 0403626B1 EP 19900900743 EP19900900743 EP 19900900743 EP 90900743 A EP90900743 A EP 90900743A EP 0403626 B1 EP0403626 B1 EP 0403626B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- bottle
- stopper
- substance
- bottle according
- stopper means
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 title claims abstract description 27
- 238000003860 storage Methods 0.000 title claims description 28
- 239000002775 capsule Substances 0.000 claims abstract description 28
- 238000004108 freeze drying Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000012907 medicinal substance Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 2
- 238000007789 sealing Methods 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 13
- 230000004913 activation Effects 0.000 description 11
- 229940088679 drug related substance Drugs 0.000 description 10
- 239000008186 active pharmaceutical agent Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 6
- 238000004891 communication Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000002663 nebulization Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 230000008646 thermal stress Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/02—Internal fittings
- B65D25/04—Partitions
- B65D25/08—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents
- B65D25/082—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents the partition being in the form of a plug or the like which is removed by increasing or decreasing the pressure within the container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2031—Separating means having openings brought into alignment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2037—Separating means having valve means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2041—Separating means having removable plugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2058—Connecting means having multiple connecting ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2058—Connecting means having multiple connecting ports
- A61J1/2062—Connecting means having multiple connecting ports with directional valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2068—Venting means
- A61J1/2075—Venting means for external venting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2079—Filtering means
- A61J1/2082—Filtering means for gas filtration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0053—Syringes, pipettes or oral dispensers
Definitions
- the present invention relates to a sterile double-compartment storage and transfer vial, designed to store two components of a drug substance, namely a solid substance and a solvent, and to transfer this substance directly, or after having mixed it with another substance, in a device for use.
- the medicinal substances whether they can be used directly or whether they constitute the components of a mixture, are usually stored in containers which can either be flame-sealed glass ampoules or bottles sealed with a stopper shutter.
- Such a bottle is for example described by American patent US-A-3,674,028 and comprises a body provided with a narrowed neck and a central constriction which defines two compartments respectively containing a lyophilisate and a solvent intended to be mixed.
- the bottle is made of a rigid material, preferably glass, to be able to be sealed in a sealed manner by means of a flexible stopper and to be able to withstand the thermal stresses of freeze-drying and sterilization in an autoclave.
- the neck is closed by a special plug allowing the evacuation of vapors during the lyophilization of the substance deposited in the lower compartment.
- This obturator comprises a central zone of lesser thickness, intended to be pierced by a needle for the purpose of withdrawing the mixture to be injected from a patient.
- disposable transfer devices have been developed to allow sterile transfer of a medicinal substance contained in a storage vial directly to a use device.
- Transfer set which has a double needle or a double trocar, and which is used to directly connect a bottle closed by an elastomer stopper with a pocket or an infusion bottle.
- the vial may contain a liquid or dry drug substance.
- the transfer device is however supplied independently of the bottle to which it is supposed to connect, and presented in sterile packaging. Therefore, nothing prevents its re-use on another bottle after a first use, even if the rules of hospital hygiene prohibit such re-use.
- the only way to prevent both handling errors during the installation of a transfer device and its reuse, is to provide a bottle equipped with a non-removable transfer device.
- the system which is the subject of American patent US-A-3,206,080 is one of these achievements. It comprises a rigid bottle which is associated with a transfer device defining a variable volume chamber, the walls of which are flexible, and which is located between the bottle itself and a trocar. This intermediate chamber acts as a pump and allows the evacuation of the solution contained in the bottle.
- closure members are not intended to allow the bottle to be closed in a lyophilization enclosure. No measures are taken to prevent accidental activation during storage. The sterility of the device cannot be preserved during storage. The construction of the assembly is complicated and difficult to carry out.
- the device described comprises an external bottle with flexible walls, provided with a neck in which an internal bottle with rigid cylindrical walls has been engaged which is intended to contain a substance to be mixed before use with another substance in the outer bottle.
- the internal bottle has lateral openings which allow it, after activation of the assembly, to deliver the mixture of the two substances, through internal channels of a transfer device.
- the seal between the outer bottle and the inner bottle is theoretically achieved at the neck. Since the outer bottle is made of flexible synthetic material and the inner bottle is made of rigid synthetic material, or made of glass, a seal preventing bacterial contamination during long-term storage cannot be guaranteed. This: the guarantee is only obtained with a seal using an elastomer plug.
- the outer bottle is not suitable for lyophilization or sterilization in an oven, since it could not withstand thermal stresses. Even if this bottle was able to withstand the constraints imposed for the lyophilization of a substance that it should contain, it could not be closed in the lyophilization enclosure, since the closure is done by means of the inner bottle.
- the sterility of the transfer device is not guaranteed during storage and nothing is provided to prevent accidental activation during this storage, or to guarantee inviolability.
- the present invention proposes to overcome the above drawbacks by providing a storage bottle which can be connected to all kinds of receptacles or containers on the market, without any noticeable increase in the cost of manufacture and without technical complications.
- the bottle according to the invention corresponds to the definition set out in claim 1.
- said closure member is mounted on a capsule fitted to the neck of the bottle and axially movable between said storage position and said position of use.
- the capsule is provided with a conical connection end piece and with a stiffening element engaged inside a cavity of the closure member.
- the connection endpiece carries a needle
- the capsule is provided with a substantially cylindrical protective element whose length is at least approximately equal to that of said needle.
- the bottle has connecting means for flexibly binding it to the device for use or to another container containing another component of the drug substance.
- Said connecting means preferably comprise a lace, the ends of which are equipped with locking connecting elements.
- the bottle can include at least one filter mounted in the connection device or the obturation member, in a zone of obligatory passage of the drug substance or of the mixture of this substance with another substance before its use.
- this filter is of the membrane filter type.
- the closure member When said device is in its first so-called storage position, the closure member can be linked to the bottle by a tamper-evident label.
- said needle advantageously comprises at least one lateral opening arranged to allow the evacuation of an overpressure generated inside the bottle and / or another container. connected to the vial by means of said needle.
- the shutter member may include a vent and an elastic shutter element arranged to close said vent in a first position and to release it in a second position.
- said vent is formed in a wall of the capsule and the closure member carries a hydrophobic filter disposed over said vent.
- this hydrophobic filter has an annular shape and has a central opening which ensures communication between the shutter member and the connection device.
- the closure member consists of at least two parts, a head and an annular seal.
- the head and the seal of this closure member are made of different materials.
- a bottle 10 provided with a closed bottom 11 and an open neck 12, of section narrowed relative to that of the body of the bottle, has a central narrowing 13 which separates a first lower compartment 14 of a second upper compartment 15.
- the lower compartment 14 is partially filled by means of an aqueous solution 16 which is introduced through a filling tube 17.
- the freeze-drying phase is represented by FIG. 2.
- This operation is carried out inside a device essentially comprising an enclosure connected to a vacuum pump and cryogenic means.
- the bottle 10 Before entering this enclosure, the bottle 10 is equipped with a stopper 18, hereinafter called a movable intermediate stopper, which comprises at its lower end a nozzle 19 provided with at least one lateral opening 20 allowing the vapor to water 21 to escape from the bottle.
- a stopper 18 hereinafter called a movable intermediate stopper, which comprises at its lower end a nozzle 19 provided with at least one lateral opening 20 allowing the vapor to water 21 to escape from the bottle.
- the next phase consists in driving the movable intermediate plug 18 inside the neck 12 to ensure a tight closure of the bottle.
- this plug is pushed in as shown by the arrows A by means of a pusher 22.
- this pusher is made up of the ceiling of the lyophilization enclosure which is lowering.
- the ceiling of the freeze-drying enclosure is fixed and it is the floor supporting the bottles which moves upwards to cause the penetration of the mobile intermediate stopper inside the neck. This procedure allows the aseptic and sealed closure of the bottle under a controlled atmosphere.
- the position of the movable intermediate plug as shown in Figure 3 is transient. In fact, this stopper is intended for sealingly separating the lower compartment 14 from the upper compartment 15.
- the phase which consists in bringing this stopper into its storage position is shown in FIG. 4.
- the movable intermediate stopper 18 is pushed through the neck, then through the upper compartment 15 in the throttle 13 by a pusher 23 mounted at the end of a rod 24 axially movable.
- This plug 18 is pressed in such a way that the end piece 19 comprising at least one lateral opening 20 is entirely located inside the lower compartment 14 and that the upper part ensures perfect sealing between the two compartments.
- the upper compartment 15 is degassed by injecting, as shown by the arrows B, a gas 25 through the rod 24 of the pusher 23, this rod being provided with at least a radial opening 26 allowing the gas to invade the upper compartment 15.
- This gas is a neutral gas having no reaction with the solvent intended to be subsequently introduced into the upper compartment.
- Figure 5 shows the filling phase of the upper compartment 15 with a solvent 27 which is poured through a supply tube 28 engaged in the neck 12 of the bottle.
- the bottle is equipped with a flexible closure member 29 which is engaged inside the neck 12 and which has a inner cavity 30 and at least one radial duct 31 whose role will be defined later.
- FIG. 7 illustrates the complete installation of the closure device which consists of the closure member 29 and of a capsule 32 provided with a stiffening element 33, of substantially cylindrical shape, which engages the inside the cavity 30 of the shutter member 29 and of a connection end piece 34 intended to ensure the connection with a user device (not shown).
- This connection end piece 34 is conical and, in the example shown in the figure, is an end piece of the female Luer type.
- the capsule 32 also includes a peripheral flange 35 which is engaged over the rim 36 of the neck 12 of the bottle 10 and which carries internal protrusions 37 and 38 having the object of cooperating with the rim 36 to define, on the one hand the storage position and on the other hand the position of use defined above.
- FIG. 8 illustrates the final phase of fitting a tamper-evident label 41 which extends above the support area of the free edge of the cap 39 on the outside wall of the bottle 10.
- the cap 39 is first removed by tearing off the tamper-evident label 41.
- the closure member 29 is then pushed inside the neck 12.
- the radial channel 31 remains closed since its orifice remains in abutment against the inner wall of the neck 12.
- This penetration also has the effect of generating a pressure which is transmitted, by means of the liquid contained in the upper compartment 15, to the movable intermediate plug 18 which is pushed back inside the lower compartment 14. This plug falls into this compartment which ensures communication between the two compartments and causes the liquid to flow into the lower compartment.
- the solvent dissolves the lyophilisate and forms a ready-to-use liquid drug substance.
- the capsule To activate the transfer device previously connected either to another container, or to any device of use known per se, equipped with a conical tip, for example of the Luer type, complementary to the conical tip 34, the capsule towards the inside of the bottle until the protuberance 38 exceeds the rim 36 of the neck 12. In this position, the closure member 29 is pressed enough towards the inside of the bottle for the radial conduit to open into the upper compartment. Communication with the user device is ensured through the transfer device.
- a conical tip for example of the Luer type
- FIGS. 9 and 10 show a bottle 10 identical to that of the preceding figures and the neck of which is closed by a closure member 50.
- This closure member comprises a lower part 51 whose outside diameter is slightly greater than the inside diameter of the neck, so as to ensure closure of the bottle, and an upper part 52 whose diameter is narrower.
- An inner cavity 53 is formed in this shutter member and is closed at its upper end by a wall 54 of relatively small thickness.
- the upper part 52 of the closure member 50 is engaged in a central opening of a capsule 55 whose outer rim is mounted on the neck of the bottle.
- a protective cap 56 is preferably placed over the capsule 55 and the closure member 50.
- a tamper-evident label 57 is fixed so as to cover the junction line of the cap and from the bottle.
- the bottle of FIG. 11 is original by the construction of the capsule 60 which covers the neck 12 of the bottle 10.
- This capsule 60 is provided with a connection device constituted by a connection end piece 61 which defines an interior cavity 62 aux conical walls.
- This interior cavity is dimensioned to be able to receive a needle-holder tip 63 of a conventional syringe 64.
- the activation of the bottle is carried out in a manner identical to that which has been described with reference to FIGS. 7 and 8.
- the solution contained inside the bottle after mixing the lyophilisate and the solvent, can be transferred to the inside the syringe 64 by simple aspiration by means of the piston 65 of this syringe.
- the bottle of FIG. 12 comprises a capsule 70 which is extended by a tubular element 71 making it possible to protect a needle 72 secured to a needle holder element 73 mounted on a conical tip 74 secured to the capsule 70.
- the needle 72 is intended to perforate a sealing plug 75 which ensures the tight closure of a flexible bag 76 which may contain a medicinal solution, a physiological liquid or distilled water etc., to which the caregiver must mix the solution obtained after activation of the bottle 10.
- the transfer can be carried out alternately in both directions, that is to say from the bag to the bottle and from the bottle to the bag until the total quantity of the liquid contained in the bottle is transferred. in the pocket.
- the closure member 76 may, in a conventional manner, include a radial channel for the flow of the liquid. However, in the embodiment shown, it consists of two parts, a head 77 made of a material compatible with the substances contained in the bottle, and a seal 78 which can be made of a material any elastomer since it is not constantly in contact with the solvent contained in the upper chamber of the bottle 10.
- FIG. 13 illustrates a form of use of the bottle 10 in which there is a connection of this bottle with a three-way valve 80.
- This connection is made by means of a connection device 81 of the Luer-Lock type, that is to say by means of a conical connection with locking.
- This connection is made on a connection endpiece 82 which is integral with the capsule 83 mounted on the neck 12 of the bottle.
- the capsule 100 is extended by a tubular element 101 which is intended for absorption by the oral route of the solution contained inside the bottle 10.
- FIG. 16 illustrates a connection of the bottle 10 to a pump 110, for example to a peristaltic micropump, by means of a flexible conduit 111 which is connected by means of a connection member 112 of the Luer-Lock type to a tip 113 extending the capsule 114 mounted on the neck 12 of the bottle 10.
- FIG. 17 illustrates a transfer device which consists of an end piece 120 extending the capsule 121, this end piece being capped by a closure element 122 based on the Luer-Lock principle.
- a cap 123 covers this assembly and a tamper-evident label 124 covers the junction zone between the free end of the cap and the body of the bottle 10.
- FIG. 18 illustrates a bottle 10 fitted with a capsule 130 which is extended by a tubular element 131 intended to protect a needle 132 mounted on a needle holder 133 which is engaged on the conical end piece 134 secured to the bottom of the capsule 130.
- the neck of the bottle 10 is closed by a shutter member 136 made in two parts, the part 137 which constitutes the head of the shutter member and a seal 138 which constitutes its base.
- the advantage of this construction lies in the fact that the two parts can be made of different materials.
- the head 137 can be made of a material compatible with the drug substance, while the seal 138, which is in contact with this substance only for a very short period of time, can be made of a material which would not withstand the contact with this substance during a storage period which can be relatively long.
- FIG. 19 illustrates a particular use of a bottle as described.
- This bottle 10 is housed inside a box 140 which contains a vaporization or nebulization device which comprises an ultrasonic generator (not shown) intended to spray in the form of very fine droplets the drug substance initially contained in the bottle .
- This substance is sucked through a conduit 141 by a micropump 142 and then discharged towards a mouthpiece 143.
- the bottle 10 must be activated, that is to say that the movable intermediate plug 18 must be pushed back into the compartment furthest from the neck of the bottle and the flexible closure member 29 must be partially pushed back into the other compartment to clear the radial channel and allow the liquid to flow.
- the bottle 10 is carried by a support 144 integral with the housing and which comprises a cylindrical cavity intended to receive a stopper 145 provided with an axial duct for the passage of a needle 146 allowing the passage of air inside the bottle and guaranteeing the operation of the micropump which sucks the liquid from the bottle , the volume withdrawn being replaced by an equivalent volume of air.
- An elastic membrane 147 is disposed above the plug 145. It ensures the sealed closure of the liquid flow circuit, below the zone of connection to the conduit 141.
- the needle 146 is carried by a nozzle 148 which is provided a sterilizing filter 149.
- the support 144 is mounted on a door 150 pivoting about an axis 151 and making it possible to set up a bottle after activation and after having emptied an empty bottle.
- the spraying of the liquid is controlled by a pusher 152.
- Figure 20 shows a perspective view of a particular embodiment of the movable intermediate plug. It consists of an upper part 160 of cylindrical shape and a lower part 161 having a substantially elliptical section, the largest dimension being equal to the diameter of the cylindrical part 160.
- the stopper is put in place. on the bottle so that the lower part 161 is partially engaged in the neck, which allows the evacuation of gases and vapors contained in the bottle. As soon as the upper part 160 is engaged in the neck, the bottle is sealed.
- the bottle described above fully meets the constraints imposed in terms of storage and use of medicinal substances. It is inviolable. It has a blocking system which makes it inactivable during storage. It includes a transfer device secured to the actual bottle which is stable and does not fear pressure or radial stress. It guarantees the sterility of the contents and the interior space including the volumes of the transfer device which are put in communication with the interior space in the bottle at the time of use.
- the locking due to the tamper-evident label and to the storage security system is eliminated with a single gesture.
- Activation of the bottle and its transfer device is carried out in a simple manner, without effort, and without piercing a closure cap. Activation is irreversible and there is no way to allow return to the storage position. This activation can be done without external equipment, next to the patient. The transfer takes place in a vacuum, without contact with the outside.
- the bottle and another container are coupled using standard members, the characteristics of which are well known.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
La présente invention concerne un flacon de stockage et de transfert stérile à double compartiment, conçu pour stocker deux composants d'une substance médicamenteuse, à savoir une substance solide et un solvant, et pour transférer cette substance directement, ou après l'avoir mélangée à une autre substance, dans un dispositif d'utilisation.The present invention relates to a sterile double-compartment storage and transfer vial, designed to store two components of a drug substance, namely a solid substance and a solvent, and to transfer this substance directly, or after having mixed it with another substance, in a device for use.
les substances médicamenteuses, qu'elles soient utilisables directement ou qu'elles constituent les composants d'un mélange, sont habituellement stockées dans des récipients qui peuvent être soit des ampoules en verre scellées à la flamme, soit des flacons obturés par un bouchon d'obturation.the medicinal substances, whether they can be used directly or whether they constitute the components of a mixture, are usually stored in containers which can either be flame-sealed glass ampoules or bottles sealed with a stopper shutter.
Un tel flacon est par exemple décrit par le brevet américain US-A-3,674,028 et comporte un corps pourvu d'un col rétréci et d'un étranglement central qui définit deux compartiments contenant respectivement un lyophilisat et un solvant destinés à être mélangés. Le flacon est réalisé en un matériau rigide, de préférence en verre, pour pouvoir être obturé de manière étanche au moyen d'un bouchon souple et pour pouvoir résister aux contraintes thermiques de la lyophilisation et de la stérilisation en autoclave. Le col est obturé par un bouchon spécial permettant l'évacuation des vapeurs lors de la lyophilisation de la substance déposée dans le compartiment inférieur. Après la lyophilisation le bouchon est repoussé dans la zone centrale du corps comportant l'étranglement et sépare ainsi de manière étanche les deux compartiments. Un obturateur est mis en place à l'extrémité du col pour fermer le compartiment supérieur après remplissage de ce dernier. Cet obturateur comporte une zone centrale de moindre épaisseur, destinée à être percée par une aiguille en vue du prélèvement du mélange à injecter à un patient.Such a bottle is for example described by American patent US-A-3,674,028 and comprises a body provided with a narrowed neck and a central constriction which defines two compartments respectively containing a lyophilisate and a solvent intended to be mixed. The bottle is made of a rigid material, preferably glass, to be able to be sealed in a sealed manner by means of a flexible stopper and to be able to withstand the thermal stresses of freeze-drying and sterilization in an autoclave. The neck is closed by a special plug allowing the evacuation of vapors during the lyophilization of the substance deposited in the lower compartment. After the freeze-drying, the plug is pushed back into the central zone of the body comprising the constriction and thus separates the two compartments in a sealed manner. A shutter is placed at the end of the neck to close the upper compartment after filling it. This obturator comprises a central zone of lesser thickness, intended to be pierced by a needle for the purpose of withdrawing the mixture to be injected from a patient.
Ces ampoules connues qui contiennent une substance médicamenteuse liquide posent un problème important lors du transfert de leur contenu dans un dispositif d'utilisation tel qu'une seringue. En effet, le soignant doit, dans tous les cas, utiliser une aiguille pour aspirer le liquide de l'ampoule. Or l'aiguille utilisée pour effectuer ce transfert est contaminée sur ses parois extérieures par la solution médicamenteuse. Cette contamination externe de l'aiguille est responsable de douleurs, d'hématomes ou d'autres lésions des tissus qui ne doivent en principe pas être en contact avec la substance médicamenteuse. En outre, le transfert ne permet pas d'éviter une contamination bactérienne et particulaire. En raison des règles d'hygiène, on impose une non-réutilisation de l'aiguille de transfert et son remplacement par une aiguille neuve stérile, et cela pour chaque opération de transfert.These known ampoules which contain a liquid medicinal substance pose a significant problem during the transfer of their contained in a device for use such as a syringe. In fact, the caregiver must, in all cases, use a needle to aspirate the liquid from the ampoule. However, the needle used to carry out this transfer is contaminated on its outer walls by the drug solution. This external contamination of the needle is responsible for pain, bruising or other tissue damage which should in principle not be in contact with the drug substance. In addition, the transfer does not prevent bacterial and particulate contamination. Due to hygienic rules, the transfer needle is not to be reused and replaced with a new sterile needle, for each transfer operation.
Cependant, rien ne garantit que le soignant respecte cette règle. Il existe de ce fait un véritable danger pour le patient, en particulier lorsque l'aiguille de transfert est également utilisée pour procéder à l'injection. La mise en contact des tissus avec la substance médicamenteuse et les contaminants, bactéries, et particules transportés par l'aiguille est alors inévitable.However, there is no guarantee that the caregiver respects this rule. There is therefore a real danger for the patient, especially when the transfer needle is also used for the injection. It is therefore inevitable that the tissues come into contact with the drug substance and the contaminants, bacteria and particles transported by the needle.
Le problème est sensiblement identique lorsque la substance est contenue dans un flacon, mais dans ce cas s'ajoutent les inconvénients connus de la perforation de bouchons.The problem is almost identical when the substance is contained in a bottle, but in this case there are the known disadvantages of puncturing plugs.
Pour pallier ces inconvénients, on a développé des dispositifs de transfert jetables pour permettre un transfert stérile d'une substance médicamenteuse contenue dans un flacon de stockage directement vers un dispositif d'utilisation.To overcome these drawbacks, disposable transfer devices have been developed to allow sterile transfer of a medicinal substance contained in a storage vial directly to a use device.
Parmi les systèmes qui sont actuellement commercialisés couramment, figure un dispositif appelé "Transfer set" qui comporte une double aiguille ou un double trocart, et qui est utilisé pour connecter directement un flacon obturé par un bouchon en élastomère avec une poche ou une bouteille à perfusion. Le flacon peut contenir une substance médicamenteuse liquide ou sèche. Le dispositif de transfert est toutefois fourni indépendamment du flacon auquel on est censé le raccorder, et présenté dans un emballage stérile. De ce fait, rien n'empêche sa réutilisation sur un autre flacon après une première utilisation, même si les règles d'hygiène hospitalière proscrivent un tel réemploi.Among the systems which are currently commercially available, there is a device called "Transfer set" which has a double needle or a double trocar, and which is used to directly connect a bottle closed by an elastomer stopper with a pocket or an infusion bottle. . The vial may contain a liquid or dry drug substance. The transfer device is however supplied independently of the bottle to which it is supposed to connect, and presented in sterile packaging. Therefore, nothing prevents its re-use on another bottle after a first use, even if the rules of hospital hygiene prohibit such re-use.
Le coût relativement élevé de ce système accentue la tendance à une réutilisation.The relatively high cost of this system accentuates the tendency to reuse.
Le seul moyen d'empêcher à la fois les erreurs de manipulation lors de la mise en place d'un dispositif de transfert et sa réutilisation, est de prévoir un flacon équipé d'un dispositif de transfert inamovible.The only way to prevent both handling errors during the installation of a transfer device and its reuse, is to provide a bottle equipped with a non-removable transfer device.
Diverses réalisations ont été proposées pour résoudre ce problème de l'industrie pharmaceutique et des milieux médicaux. Le système faisant l'objet du brevet américain US-A-3,206,080 est l'une de ces réalisations. Il comporte un flacon rigide qui est associé à un dispositif de transfert définissant une chambre à volume variable, dont les parois sont flexibles, et qui se situe entre le flacon proprement dit et un trocart. Cette chambre intermédiaire fait office de pompe et permet l'évacuation de la solution contenue dans le flacon.Various embodiments have been proposed to solve this problem of the pharmaceutical industry and the medical community. The system which is the subject of American patent US-A-3,206,080 is one of these achievements. It comprises a rigid bottle which is associated with a transfer device defining a variable volume chamber, the walls of which are flexible, and which is located between the bottle itself and a trocar. This intermediate chamber acts as a pump and allows the evacuation of the solution contained in the bottle.
Cette construction ne permet pas de résoudre les problèmes posés. En particulier, les organes d'obturation ne sont pas prévus pour permettre une fermeture du flacon dans une enceinte de lyophilisation. Aucune mesure n'est prise pour empêcher toute activation accidentelle pendant le stockage. La stérilité du dispositif ne peut pas être préservée pendant le stockage. La construction de l'ensemble est compliquée et difficile à réaliser.This construction does not solve the problems posed. In particular, the closure members are not intended to allow the bottle to be closed in a lyophilization enclosure. No measures are taken to prevent accidental activation during storage. The sterility of the device cannot be preserved during storage. The construction of the assembly is complicated and difficult to carry out.
Une autre réalisation de ce type est décrite par le brevet américain US-A-4,657,534. Le dispositif décrit comporte un flacon extérieur à parois souples, pourvu d'un col dans lequel on a engagé un flacon intérieur à parois cylindriques rigides qui est destiné à contenir une substance devant être mélangée avant utilisation à une autre substance contenue dans le flacon extérieur. Le flacon intérieur comporte des ouvertures latérales qui lui permettent, après activation de l'ensemble, de délivrer le mélange des deux substances, à travers des canaux intérieurs d'un dispositif de transfert.Another embodiment of this type is described by American patent US-A-4,657,534. The device described comprises an external bottle with flexible walls, provided with a neck in which an internal bottle with rigid cylindrical walls has been engaged which is intended to contain a substance to be mixed before use with another substance in the outer bottle. The internal bottle has lateral openings which allow it, after activation of the assembly, to deliver the mixture of the two substances, through internal channels of a transfer device.
Ce système ne répond pas non plus aux exigences actuelles en matière de stockage et de transfert de substances médicamenteuses. L'étanchéité entre le flacon extérieur et le flacon intérieur est théoriquement réalisée au niveau du col. Le flacon extérieur étant en une matière synthétique souple et le flacon intérieur en une matière synthétique rigide, ou en verre, une étanchéité empêchant une contamination bactérienne lors d'un stockage de longue durée ne peut pas être garantie. Ce:te garantie n'est obtenue qu'avec une obturation au moyen d'un bouchon en élastomère. Le flacon extérieur ne se prête ni à une lyophilisation ni à une stérilisation en étuve, puisqu'il ne pourrait pas supporter les contraintes thermiques. Même si ce flacon était en mesure de résister aux contraintes imposées pour la lyophilisation d'une substance qu'il devrait contenir, il ne pourrait pas être obturé dans l'enceinte de lyophilisation, puisque l'obturation se fait au moyen du flacon intérieur.This system also does not meet current requirements for storage and transfer of drug substances. The seal between the outer bottle and the inner bottle is theoretically achieved at the neck. Since the outer bottle is made of flexible synthetic material and the inner bottle is made of rigid synthetic material, or made of glass, a seal preventing bacterial contamination during long-term storage cannot be guaranteed. This: the guarantee is only obtained with a seal using an elastomer plug. The outer bottle is not suitable for lyophilization or sterilization in an oven, since it could not withstand thermal stresses. Even if this bottle was able to withstand the constraints imposed for the lyophilization of a substance that it should contain, it could not be closed in the lyophilization enclosure, since the closure is done by means of the inner bottle.
En outre, la stérilité du dispositif de transfert n'est pas garantie pendant le stockage et rien n'est prévu pour empêcher une activation accidentelle pendant ce stockage, ou pour garantir l'inviolabilité.In addition, the sterility of the transfer device is not guaranteed during storage and nothing is provided to prevent accidental activation during this storage, or to guarantee inviolability.
En effet pour qu'un système de transfert réponde à toutes les exigences en matière de sécurité il est indispensable qu'il soit inviolable, inactivable pendant le stockage, solidaire du flacon, résistant à une contrainte radiale, stérile et garantissant la stérilité de l'espace intérieur du flacon et de tous les canaux, cavités intérieures et orifices permettant de faire communiquer cet espace avec un autre espace délimité par un autre récipient pouvant contenir un autre composant destiné à être mélangé à la substance contenue dans le flacon.Indeed, for a transfer system to meet all the security requirements, it is essential that it be tamper-proof, inactivable during storage, secured to the bottle, resistant to radial stress, sterile and guaranteeing the sterility of the interior space of the bottle and all the channels, interior cavities and orifices making it possible to communicate this space with another space delimited by another container which may contain another component intended to be mixed with the substance contained in the bottle.
La présente invention se propose de pallier les inconvénients ci-dessus en réalisant un flacon de stockage pouvant être connecté à toutes sortes de récipients ou conteneurs du marché, sans augmentation notoire du coût de fabrication et sans complications techniques.The present invention proposes to overcome the above drawbacks by providing a storage bottle which can be connected to all kinds of receptacles or containers on the market, without any noticeable increase in the cost of manufacture and without technical complications.
Dans ce but, le flacon selon l'invention correspond à la définition énoncée par la revendication 1.For this purpose, the bottle according to the invention corresponds to the definition set out in claim 1.
Selon une forme de réalisation préférée, ledit organe d'obturation est monté sur une capsule ajustée sur le col du flacon et mobile axialement entre ladite position de stockage et ladite position d'utilisation.According to a preferred embodiment, said closure member is mounted on a capsule fitted to the neck of the bottle and axially movable between said storage position and said position of use.
De préférence, la capsule est pourvue d'un embout de raccordement conique et d'un élément raidisseur engagé à l'intérieur d'une cavité de l'organe d'obturation.
Selon une forme de réalisation avantageuse dans laquelle l'embout de raccordement porte une aiguille, la capsule est pourvue d'un élément de protection sensiblement cylindrique dont la longueur est au moins approximativement égale à celle de ladite aiguille.Preferably, the capsule is provided with a conical connection end piece and with a stiffening element engaged inside a cavity of the closure member.
According to an advantageous embodiment in which the connection endpiece carries a needle, the capsule is provided with a substantially cylindrical protective element whose length is at least approximately equal to that of said needle.
Selon une variante, le flacon comporte des moyens de liaison pour le lier de façon souple au dispositif d'utilisation ou à un autre récipient contenant un autre composant de la substance médicamenteuse.Alternatively, the bottle has connecting means for flexibly binding it to the device for use or to another container containing another component of the drug substance.
Lesdits moyens de liaison comprennent de préférence un lacet dont les extrémités sont équipées d'éléments de liaison à verrouillage.Said connecting means preferably comprise a lace, the ends of which are equipped with locking connecting elements.
D'une façon avantageuse, le flacon peut comporter au moins un filtre monté dans le dispositif de raccordement ou l'organe d'obturation, dans une zone de passage obligatoire de la substance médicamenteuse ou du mélange de cette substance avec une autre substance avant son utilisation. De préférence, ce filtre est du type filtre à membrane.Advantageously, the bottle can include at least one filter mounted in the connection device or the obturation member, in a zone of obligatory passage of the drug substance or of the mixture of this substance with another substance before its use. Preferably, this filter is of the membrane filter type.
Lorsque ledit dispositif se trouve dans sa première position dite de stockage, l'organe d'obturation peut être lié au flacon par une étiquette d'inviolabilité.When said device is in its first so-called storage position, the closure member can be linked to the bottle by a tamper-evident label.
Lorsque le dispositif de transfert comporte une aiguille pour perforer un bouchon d'obturation, ladite aiguille comporte avantageusement au moins une ouverture latérale agencée pour permettre l'évacuation d'une surpression engendrée à l'intérieur du flacon et/ou d'un autre conteneur connecté au flacon au moyen de ladite aiguille.When the transfer device comprises a needle for perforating a closure plug, said needle advantageously comprises at least one lateral opening arranged to allow the evacuation of an overpressure generated inside the bottle and / or another container. connected to the vial by means of said needle.
L'organe d'obturation peut comporter un évent et un élément d'obturation élastique agencé pour obturer ledit évent dans une première position et pour le libérer dans une deuxième position.The shutter member may include a vent and an elastic shutter element arranged to close said vent in a first position and to release it in a second position.
D'une façon avantageuse, ledit évent est ménagé dans une paroi de la capsule et l'organe d'obturation porte un filtre hydrophobe disposé par-dessus ledit évent.Advantageously, said vent is formed in a wall of the capsule and the closure member carries a hydrophobic filter disposed over said vent.
De préférence, ce filtre hydrophobe a une forme annulaire et comporte une ouverture centrale qui assure la communication entre l'organe d'obturation et le dispositif de raccordement.Preferably, this hydrophobic filter has an annular shape and has a central opening which ensures communication between the shutter member and the connection device.
Selon une autre forme de réalisation avantageuse, l'organe d'obturation se compose d'au moins deux parties, une tête et un joint annulaire. De préférence, la tête et le joint de cet organe d'obturation sont réalisés en des matériaux différents.According to another advantageous embodiment, the closure member consists of at least two parts, a head and an annular seal. Preferably, the head and the seal of this closure member are made of different materials.
L'invention sera mieux comprise en référence à la description d'exemples de réalisation et du dessin annexé dans lequel :
- les figures 1 à 5 illustrent les phases de remplissage d'un flacon à deux compartiments selon l'invention,
- la figure 6 représente la phase de mise en place de l'organe d'obturation,
- la figure 7 représente la phase de mise en place d'une forme de réalisation du dispositif d'obturation complet et du dispositif de transfert,
- la figure 8 représente la phase de mise en place d'une étiquette d'inviolabilité,
- les figures 9 et 10 représentent une autre forme de réalisation du dispositif d'obturation,
- la figure 11 illustre un dispositif de transfert prévu pour être accouplé à une seringue traditionnelle,
- la figure 12 représente l'accouplement du flacon à une poche souple pourvue d'un embout obturé par un bouchon à percer,
- la figure 13 représente la connexion du dispositif de transfert avec un robinet à trois voies,
- la figure 14 représente le flacon de l'invention connecté à un flacon souple à un seul compartiment,
- la figure 15 représente un dispositif de transfert constitué d'un embout prévu pour être mis en bouche par le patient,
- la figure 16 représente le flacon de l'invention raccordé à une micropompe,
- la figure 17 illustre un embout de raccordement conique du type dit Luer-Lock,
- la figure 18 illustre un dispositif de raccordement du type infusions,
- la figure 19 correspond à une utilisation particulière du flacon selon l'invention, en combinaison avec un dispositif de nébulisation sans gaz propulseur pour inhalations, et
- la figure 20 représente une vue en perspective d'une forme de réalisation particulière du bouchon intermédiaire mobile séparant les deux compartiments du flacon.
- FIGS. 1 to 5 illustrate the filling phases of a bottle with two compartments according to the invention,
- FIG. 6 represents the phase of fitting the shutter member,
- FIG. 7 represents the phase of setting up an embodiment of the complete sealing device and of the transfer device,
- FIG. 8 represents the phase of putting in place a tamper-evident label,
- FIGS. 9 and 10 show another embodiment of the shutter device,
- FIG. 11 illustrates a transfer device intended to be coupled to a traditional syringe,
- FIG. 12 represents the coupling of the bottle to a flexible bag provided with a nozzle closed by a plug to be drilled,
- FIG. 13 represents the connection of the transfer device with a three-way tap,
- FIG. 14 represents the bottle of the invention connected to a flexible bottle with a single compartment,
- FIG. 15 represents a transfer device consisting of a nozzle intended to be placed in the mouth by the patient,
- FIG. 16 represents the bottle of the invention connected to a micropump,
- FIG. 17 illustrates a conical connection end piece of the so-called Luer-Lock type,
- FIG. 18 illustrates a connection device of the infusion type,
- FIG. 19 corresponds to a particular use of the bottle according to the invention, in combination with a nebulization device without propellant gas for inhalations, and
- FIG. 20 represents a perspective view of a particular embodiment of the movable intermediate stopper separating the two compartments of the bottle.
En référence à la figure 1, un flacon 10 pourvu d'un fond fermé 11 et d'un col 12, ouvert, de section rétrécie par rapport à celle du corps du flacon, présente un rétrécissement central 13 qui sépare un premier compartiment inférieur 14 d'un deuxième compartiment supérieur 15. Dans une première phase, illustrée par cette figure, on remplit partiellement le compartiment inférieur 14 au moyen d'une solution aqueuse 16 qui est introduite à travers une tubulure de remplissage 17.With reference to FIG. 1, a
La phase de lyophilisation est représentée par la figure 2. Cette opération se fait à l'intérieur d'un appareil comportant essentiellement une enceinte reliée à une pompe à vide et des moyens de cryogénation. Avant de pénétrer dans cette enceinte, le flacon 10 est équipé d'un bouchon 18, appelé par la suite bouchon intermédiaire mobile, qui comporte à son extrémité inférieure un embout 19 pourvu d'au moins une ouverture latérale 20 permettant à la vapeur d'eau 21 de s'échapper hors du flacon.The freeze-drying phase is represented by FIG. 2. This operation is carried out inside a device essentially comprising an enclosure connected to a vacuum pump and cryogenic means. Before entering this enclosure, the
On notera que cette opération est faite dans des conditions stériles étant donné que le flacon est stérile au moment de son remplissage, le bouchon intermédiaire mobile est stérile au moment de sa mise en place sur le col du flacon et l'enceinte de lyophilisation est une enceinte stérile.It will be noted that this operation is carried out under sterile conditions since the bottle is sterile at the time of filling, the mobile intermediate stopper is sterile at the time of its placement on the neck of the bottle and the lyophilization enclosure is a sterile enclosure.
La phase suivante, représentée par la figure 3 consiste à enfoncer le bouchon intermédiaire mobile 18 à l'intérieur du col 12 pour assurer une obturation étanche du flacon. Pour amener le bouchon intermédiaire mobile 18 de sa position de lyophilisation représentée par la figure 2 dans une position de fermeture étanche du flacon, on enfonce ce bouchon comme le montrent les flèches A au moyen d'un poussoir 22. Dans la pratique, ce poussoir est constitué par le plafond de l'enceinte de lyophilisation qui s'abaisse. Selon d'autres formes de réalisation, le plafond de l'enceinte de lyophilisation est fixe et c'est le plancher supportant les flacons qui se déplace vers le haut pour provoquer la pénétration du bouchon intermédiaire mobile à l'intérieur du col. Cette façon de procéder permet la fermeture aseptique et étanche du flacon sous atmosphère contrôlée.The next phase, represented by FIG. 3, consists in driving the movable
La position du bouchon intermédiaire mobile telle que représentée par la figure 3 est transitoire. En effet, ce bouchon est destiné à séparer d'une manière étanche le compartiment inférieur 14 du compartiment supérieur 15. La phase qui consiste à amener ce bouchon dans sa position de stockage est représentée par la figure 4. Le bouchon intermédiaire mobile 18 est poussé à travers le col, puis à travers le compartiment supérieur 15 dans l'étranglement 13 par un poussoir 23 monté à l'extrémité d'une tige 24 mobile axialement. Ce bouchon 18 est enfoncé de telle manière que l'embout 19 comportant au moins une ouverture latérale 20 soit entièrement situé à l'intérieur du compartiment inférieur 14 et que la partie supérieure assure une étanchéité parfaite entre les deux compartiments.The position of the movable intermediate plug as shown in Figure 3 is transient. In fact, this stopper is intended for sealingly separating the
Au cours de la phase représentée par cette même figure 4, on assure le dégazage du compartiment supérieur 15 en injectant, comme le montrent les flèches B, un gaz 25 à travers la tige 24 du poussoir 23, cette tige étant pourvue d'au moins une ouverture radiale 26 permettant au gaz d'envahir le compartiment supérieur 15. Ce gaz est un gaz neutre n'ayant aucune réaction avec le solvant destiné à être introduit par la suite dans le compartiment supérieur.During the phase represented by this same FIG. 4, the
La figure 5 représente la phase de remplissage du compartiment supérieur 15 au moyen d'un solvant 27 qui est déversé à travers une tubulure d'amenée 28 engagée dans le col 12 du flacon.Figure 5 shows the filling phase of the
Comme le montre la figure 6, après cette phase de remplissage du compartiment supérieur, le flacon est équipé d'un organe d'obturation souple 29 qui est engagé à l'intérieur du col 12 et qui comporte une cavité intérieure 30 et au moins un conduit radial 31 dont le rôle sera défini par la suite.As shown in Figure 6, after this filling phase of the upper compartment, the bottle is equipped with a
La figure 7 illustre la mise en place complète du dispositif d'obturation qui se compose de l'organe d'obturation 29 et d'une capsule 32 pourvue d'un élément raidisseur 33, de forme sensiblement cylindrique, qui s'engage à l'intérieur de la cavité 30 de l'organe d'obturation 29 et d'un embout de raccordement 34 destiné à assurer la connexion avec un dispositif d'utilisation (non représenté). Cet embout de raccordement 34 est conique et, dans l'exemple représenté par la figure, est un embout du type Luer femelle.FIG. 7 illustrates the complete installation of the closure device which consists of the
La capsule 32 comporte par ailleurs une collerette 35 périphérique qui est engagée par-dessus le rebord 36 du col 12 du flacon 10 et qui porte des protubérances intérieures 37 et 38 ayant pour objet de coopérer avec le rebord 36 pour définir, d'une part la position de stockage et d'autre part la position d'utilisation définies précédemment.The
Un capuchon de protection 39 ayant une forme sensiblement cylindrique, est monté par-dessus la capsule. On notera que le diamètre du capuchon 39 est sensiblement égal au diamètre du flacon 10 et que l'extrémité libre des parois latérales du capuchon 39 est en appui sur la paroi extérieure du flacon 10 à la base du col 12. Cet appui constitue une sécurité permettant d'éviter une activation accidentelle du dispositif d'obturation et du dispositif de transfert.A
La figure 8 illustre la phase ultime de mise en place d'une étiquette d'inviolabilité 41 qui s'étend au-dessus de la zone d'appui du bord libre du capuchon 39 sur la paroi extérieur du flacon 10.FIG. 8 illustrates the final phase of fitting a tamper-
Pour utiliser le flacon représenté dans sa position de stockage par la figure 8, on enlève tout d'abord le capuchon 39 en déchirant l'étiquette d'inviolabilité 41. On enfonce ensuite l'organe d'obturation 29 à l'intérieur du col 12. Au cours de cette pénétration, le canal radial 31 reste obturé étant donné que son orifice reste en appui contre la paroi intérieure du col 12. Cette pénétration a par ailleurs pour effet d'engendrer une pression qui se transmet, par l'intermédiaire du liquide contenu dans le compartiment supérieur 15, au bouchon intermédiaire mobile 18 qui est repoussé à l'intérieur du compartiment inférieur 14. Ce bouchon tombe dans ce compartiment ce qui permet d'assurer la communication entre les deux compartiments et provoque l'écoulement du liquide dans le compartiment inférieur. Le solvant dissout le lyophilisat et forme une substance médicamenteuse liquide prête à l'emploi. Pour activer le dispositif de transfert préalablement raccordé soit à un autre récipient, soit à un dispositif d'utilisation quelconque connu en soi, équipé d'un embout conique, par exemple du type Luer, complémentaire à l'embout conique 34, on enfonce la capsule vers l'intérieur du flacon jusqu'au moment où la protubérance 38 dépasse le rebord 36 du col 12. Dans cette position, l'organe d'obturation 29 est suffisamment enfoncé vers l'intérieur du flacon pour que le conduit radial débouche dans le compartiment supérieur. La communication avec le dispositif d'utilisation est assurée à travers le dispositif de transfert.To use the bottle shown in its storage position in FIG. 8, the
Les figures 9 et 10 représentent un flacon 10 identique à celui des figures précédentes et dont le col est obturé par un organe d'obturation 50. Cet organe d'obturation comporte une partie inférieure 51 dont le diamètre extérieur est légèrement supérieur au diamètre intérieur du col, de manière à assurer une fermeture du flacon, et une partie supérieure 52 dont le diamètre est plus étroit. Une cavité intérieure 53 est ménagée dans cet organe d'obturation et est fermée à son extrémité supérieure par une paroi 54 de relativement faible épaisseur. La partie supérieure 52 de l'organe d'obturation 50 est engagée dans une ouverture centrale d'une capsule 55 dont le rebord extérieur est monté sur le col du flacon.FIGS. 9 and 10 show a
Comme le montre la figure 10, un capuchon de protection 56 est de préférence disposé par-dessus la capsule 55 et l'organe d'obturation 50. Une étiquette d'inviolabilité 57 est fixée de manière à recouvrir la ligne de jonction du capuchon et du flacon.As shown in FIG. 10, a
Pour activer le flacon et repousser le bouchon intermédiaire mobile 18 dans le compartiment inférieur, il suffit, dans l'exemple illustré par la figure 9, de pousser la capsule sur le col et, dans l'exemple de la figure 10 d'effectuer cette manipulation après avoir préalablement enlevé le capuchon et l'étiquette.To activate the bottle and push the movable
Le flacon de la figure 11 est original par la construction de la capsule 60 qui coiffe le col 12 du flacon 10. Cette capsule 60 est pourvue d'un dispositif de raccordement constitué d'un embout de raccordement 61 qui définit une cavité intérieure 62 aux parois coniques. Cette cavité intérieure est dimensionnée pour pouvoir recevoir un embout porte-aiguille 63 d'une seringue 64 classique. L'activation du flacon s'effectue d'une manière identique à celle qui a été décrite en référence aux figures 7 et 8. La solution contenue à l'intérieur du flacon, après mélange du lyophilisat et du solvant, peut être transférée à l'intérieur de la seringue 64 par simple aspiration au moyen du piston 65 de cette seringue.The bottle of FIG. 11 is original by the construction of the
Le flacon de la figure 12 comporte une capsule 70 qui se prolonge par un élément tubulaire 71 permettant de protéger une aiguille 72 solidaire d'un élément porte-aiguille 73 monté sur un embout conique 74 solidaire de la capsule 70. L'aiguille 72 est destinée à perforer un bouchon d'obturation 75 qui assure la fermeture étanche d'une poche souple 76 pouvant contenir une solution médicamenteuse, un liquide physiologique ou de l'eau distillée etc., à laquelle le soignant doit mélanger la solution obtenue après activation du flacon 10. Le transfert peut s'effectuer alternativement dans les deux sens, c'est-à-dire de la poche vers le flacon et du flacon vers la poche jusqu'à ce que la quantité totale du liquide contenu dans le flacon soit transféré dans la poche.The bottle of FIG. 12 comprises a
L'organe d'obturation 76 peut, d'une manière classique, comporter un canal radial pour l'écoulement du liquide. Toutefois, dans la réalisation représentée, il se compose de deux parties, une tête 77 réalisée en un matériau compatible avec les substances contenues dans le flacon, et un joint 78 qui peut être fait en un matériau élastomère quelconque puisqu'il n'est pas constamment en contact avec le solvant contenu dans la chambre supérieure du flacon 10.The
La figure 13 illustre une forme d'utilisation du flacon 10 dans laquelle on assure une connexion de ce flacon avec une vanne 80 à trois voies. Cette connexion s'effectue au moyen d'un dispositif de raccordement 81 du type Luer-Lock, c'est-à-dire au moyen d'un raccordement conique à verrouillage. Ce raccordement s'effectue sur un embout de raccordement 82 qui est solidaire de la capsule 83 montée sur le col 12 du flacon.FIG. 13 illustrates a form of use of the
Dans l'exemple de réalisation de la figure 14, la vanne à trois voies a été remplacée par un flacon souple 90. On notera que les moyens de raccordement de ce flacon à l'embout de la capsule sont identiques à ceux décrits en référence à la figure 13 et portent par conséquent les mêmes numéros de référence.In the embodiment of FIG. 14, the three-way valve has been replaced by a
Dans l'exemple illustré par la figure 15, la capsule 100 est prolongée par un élément tubulaire 101 qui est destiné à une absorption par voie buccale de la solution contenue à l'intérieur du flacon 10.In the example illustrated by FIG. 15, the
La figure 16 illustre une connexion du flacon 10 à une pompe 110, par exemple à une micropompe péristaltique, par l'intermédiaire d'un conduit souple 111 qui est connecté au moyen d'un organe de raccordement 112 du type Luer-Lock à un embout 113 prolongeant la capsule 114 montée sur le col 12 du flacon 10.FIG. 16 illustrates a connection of the
La figure 17 illustre un dispositif de transfert qui est constitué par un embout 120 prolongeant la capsule 121, cet embout étant coiffé par un élément d'obturation 122 basé sur le principe du Luer-Lock. Un capuchon 123 coiffe cet ensemble et une étiquette d'inviolabilité 124 recouvre la zone de jonction entre l'extrémité libre du capuchon et le corps du flacon 10.FIG. 17 illustrates a transfer device which consists of an
La figure 18 illustre un flacon 10 équipé d'une capsule 130 qui est prolongée par un élément tubulaire 131 destiné à protéger une aiguille 132 montée sur un porte-aiguille 133 qui est engagé sur l'embout conique 134 solidaire du fond de la capsule 130.FIG. 18 illustrates a
On notera que tous ces flacons peuvent être équipés d'un filtre qui est, dans ce cas, monté à l'intérieur de la capsule. Dans l'exemple de la figure 18, ce filtre 135 est soudé par ultrasons ou collé au fond de la capsule en travers du canal radial par lequel doit obligatoirement s'écouler la solution contenue dans le flacon.It will be noted that all of these bottles can be fitted with a filter which is, in this case, mounted inside the capsule. In the example of FIG. 18, this
On notera également que le col du flacon 10 est obturé par un organe d'obturation 136 réalisé en deux parties, la partie 137 qui constitue la tête de l'organe d'obturation et un joint 138 qui en constitue la base. L'avantage de cette construction réside dans le fait que les deux parties peuvent être réalisées en des matériaux différents. La tête 137 peut être réalisée en un matériau compatible avec la substance médicamenteuse, alors que le joint 138, qui n'est en contact avec cette substance que pendant un laps de temps très court, peut être réalisé en un matériau qui ne supporterait pas le contact avec cette substance pendant une période de stockage qui peut être relativement longue.It will also be noted that the neck of the
La figure 19 illustre une utilisation particulière d'un flacon tel que décrit. Ce flacon 10 est logé à l'intérieur d'un boîtier 140 qui contient un dispositif de vaporisage ou de nébulisation qui comprend un générateur à ultrasons {non représenté) destiné à pulvériser sous forme de gouttelettes très fines la substance médicamenteuse initialement contenue dans le flacon. Cette substance est aspirée à travers un conduit 141 par une micropompe 142 puis refoulée vers un embout buccal 143. Tout d'abord, le flacon 10 doit être activé, c'est-à-dire que le bouchon intermédiaire mobile 18 doit être repoussé dans le compartiment le plus éloigné du col du flacon et l'organe d'obturation souple 29 doit être repoussé partiellement dans l'autre compartiment pour dégager le canal radial et permettre l'écoulement du liquide. Cette activation s'effectue à l'extérieur du boîtier et le flacon est monté à l'intérieur de ce boîtier après avoir été activé. Le flacon 10 est porté par un support 144 solidaire du boîtier et qui comporte une cavité cylindrique destinée à recevoir un bouchon 145 pourvu d'un conduit axial pour le passage d'une aiguille 146 permettant le passage de l'air à l'intérieur du flacon et garantissant le fonctionnement de la micropompe qui aspire le liquide du flacon, le volume prélevé étant remplacé par un volume équivalent d'air. Une membrane élastique 147 est disposée au-dessus du bouchon 145. Elle assure la fermeture étanche du circuit d'écoulement du liquide, en dessous de la zone de raccordement au conduit 141. L'aiguille 146 est portée par un embout 148 qui est pourvu d'un filtre stérilisant 149. Le support 144 est monté sur une porte 150 pivotant autour d'un axe 151 et permettant de mettre en place un flacon après activation et après avoir évacué un flacon vide. La pulvérisation du liquide est commandée par un poussoir 152.FIG. 19 illustrates a particular use of a bottle as described. This
La figure 20 représente une vue en perspective d'une forme de réalisation particulière du bouchon intermédiaire mobile. Il se compose d'une partie supérieure 160 de forme cylindrique et d'une partie inférieure 161 ayant une section sensiblement elliptique, la plus grande dimension étant égale au diamètre de la partie cylindrique 160. Lors de la lyophilisation, le bouchon est mis en place sur le flacon de telle manière que la partie inférieure 161 soit partiellement engagée dans le col, ce qui permet l'évacuation des gaz et vapeurs contenus dans le flacon. Dès que la partie supérieure 160 est engagée dans le col, le flacon est étanche.Figure 20 shows a perspective view of a particular embodiment of the movable intermediate plug. It consists of an
Le flacon décrit ci-dessus répond en tout point aux contraintes imposées en matière de conservation et d'utilisation de substances médicamenteuses. Il est inviolable. Il dispose d'un système de blocage qui le rend inactivable pendant le stockage. Il comporte un dispositif de transfert solidaire du flacon proprement dit qui est stable et ne craint pas une pression ou contrainte radiale. Il garantit la stérilité du contenu et de l'espace intérieur y compris les volumes du dispositif de transfert qui sont mis en communication avec l'espace intérieur au flacon au moment de l'utilisation.The bottle described above fully meets the constraints imposed in terms of storage and use of medicinal substances. It is inviolable. It has a blocking system which makes it inactivable during storage. It includes a transfer device secured to the actual bottle which is stable and does not fear pressure or radial stress. It guarantees the sterility of the contents and the interior space including the volumes of the transfer device which are put in communication with the interior space in the bottle at the time of use.
En outre, au moment de :'utilisation, le verrouillage dû à l'étiquette d'inviolabilité et au système de sécurité au stockage est éliminé d'un seul geste. L'activation du flacon et de son dispositif de transfert s'effectue de manière simple, sans effort, et sans percement d'un bouchon d'obturation. L'activation est irréversible et aucun moyen n'autorise le retour dans la position de stockage. Cette activation peut se faire sans appareillage extérieur, à côté du patient. Le transfert s'effectue en vase clos, sans contact avec l'extérieur. L'accouplement du flacon et d'un autre récipient s'effectue au moyen d'organes standards dont les caractéristiques sont parfaitement connues.In addition, at the time of use, the locking due to the tamper-evident label and to the storage security system is eliminated with a single gesture. Activation of the bottle and its transfer device is carried out in a simple manner, without effort, and without piercing a closure cap. Activation is irreversible and there is no way to allow return to the storage position. This activation can be done without external equipment, next to the patient. The transfer takes place in a vacuum, without contact with the outside. The bottle and another container are coupled using standard members, the characteristics of which are well known.
Claims (15)
- Double compartmented sterile storage and transfer bottle (10) designed to store two components of a medicinal substance, specifically a solid substance and a solvent, and to transfer said substance directly or after mixture with another substance to an utility device, said bottle comprising a tapered open neck (12), a stopper means engaged in said neck, this stopper means (29, 76) comprising an interior cavity (30) and at least one radial conduit (31) connected to this cavity, and a transfer device for connecting the bottle with a receptacle containing another medicinal substance and/or with the utility device, in which the stopper means (29) is designed for being displaced between a first position, called the storage position, in which it constitutes a tight stopper, the said radial conduit being closed up by the wall of the said tapered neck (12) and a second position, called the utility position, in which it constitutes an open valve for providing evacuation of the said medicinal substance towards the transfer device, the said radial conduit (31) opening into the interior of the bottle, this bottle being made of a material able to resist to the temperature strains of a lyophilisation and/or a sterilization, the transfer device being integral with the stopper means (29) and moving with it between its storage position and its utility position, and comprising a central canal connected to said interior cavity (30) of the stopper means (29), and defines a direct passage through the stopper means between the said bottle and the said receptacle containing another substance, or the said utility device, when the stopper means is in the said utility position.
- Bottle according to claim 1, characterized in that the said stopper means (29) is mounted on a capsule (32) adapted to the neck of the bottle and is axially movable between the said storage position and the said utility position.
- Bottle according to claim 2, characterized in that the capsule (32) is provided with a conical connecting tip and a tightening element (33) engaged inside the cavity (30) of the stopper means (29).
- Bottle according to claim 3, characterized in that the connecting tip is a tip (34) of the "Luer" type.
- Bottle according to claim 3, characterized in that the connecting tip is a tip (82) of the "Luer Lock" type.
- Bottle according to claim 3, characterized in that the connecting tip a conical male tip.
- Bottle according to claim 3, characterized in that the connecting tip is a conical female tip.
- Bottle according to claim 1, characterized in that the two compartments (14, 15) are separated by an intermediate stopper (18) displaceable between a storage position, in which it constitutes a sealed area between the two compartments, and a position of preparation for use in which the two compartments are interconnected so that the solvent may dissolve the solid component.
- Bottle according to claim 8, characterized in that the position of preparation for use of the movable intermediate stopper (18) is a temporary position between the storage position and the utility position of the stopper device.
- Bottle according to claim 1, characterized in that it comprises at least one filter (135) mounted in the connection device or the stopper device, in an area through which the medicinal substance or the mixture of said substance and another substance must pass before use.
- Bottle according to claim 1, characterized in that the filter is a membrane filter.
- Bottle according to claim 10, characterized in that the stopper device is connected to the bottle by a tamper-proof seal (41) when said bottle is in its first position known as the storage position.
- Bottle according to claim 1, characterized in that the connection device comprise a needle (72) disposed to puncture a stopper (75) in an empty or pre-filled receptacle.
- Bottle according to claim 1, characterized in that the stopper means (136) is comprised of at least two parts, a head (137) and an annular gasket (138).
- Bottle according to claim 14, characterized in that the head (137) and the gasket (138) on the stopper means (136) are made of different material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT90900743T ATE94749T1 (en) | 1988-12-27 | 1989-12-27 | STORAGE AND TRANSFER BOTTLE FOR STORING TWO COMPONENTS OF A HEALING SUBSTANCE. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4805/88 | 1988-12-27 | ||
CH480588 | 1988-12-27 | ||
CH392089 | 1989-10-30 | ||
CH3920/89 | 1989-10-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0403626A1 EP0403626A1 (en) | 1990-12-27 |
EP0403626B1 true EP0403626B1 (en) | 1993-09-22 |
Family
ID=25694173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19900900743 Expired - Lifetime EP0403626B1 (en) | 1988-12-27 | 1989-12-27 | Storage and transfer bottle designed for storing two components of a medicamental substance |
Country Status (8)
Country | Link |
---|---|
US (1) | US5533994A (en) |
EP (1) | EP0403626B1 (en) |
JP (1) | JPH0669475B2 (en) |
AT (1) | ATE94749T1 (en) |
CA (1) | CA2006582A1 (en) |
DE (1) | DE68909402T2 (en) |
ES (1) | ES2044548T3 (en) |
WO (1) | WO1990007319A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013006757A3 (en) * | 2011-07-06 | 2013-07-11 | Nexmed Holdings, Inc. | Reconstitution device |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE97800T1 (en) * | 1989-09-14 | 1993-12-15 | Medicorp Holding | ELONGITUDE CONTAINER WITH TWO SEPARATE CHAMBERS ON THE SAME LONGTUOUS AXIS. |
JPH0675587B2 (en) * | 1991-12-12 | 1994-09-28 | 明治製菓株式会社 | Infusion container |
US5613291A (en) * | 1995-01-25 | 1997-03-25 | Becton, Dickinson And Company | Method for providing a sterility seal in a medicinal storage bottle |
US5685845A (en) * | 1995-07-11 | 1997-11-11 | Becton, Dickinson And Company | Sterile resealable vial connector assembly |
DE19615422A1 (en) | 1996-04-19 | 1997-11-20 | Boehringer Ingelheim Kg | Two-chamber cartridge for propellant-free MDIs |
US5776124A (en) * | 1996-07-15 | 1998-07-07 | Wald; Arnold | Reusable adapter for uniting a syringe and vial |
US5871110A (en) * | 1996-09-13 | 1999-02-16 | Grimard; Jean-Pierre | Transfer assembly for a medicament container having a splashless valve |
US5873872A (en) * | 1996-09-17 | 1999-02-23 | Becton Dickinson And Company | Multipositional resealable vial connector assembly for efficient transfer of liquid |
US5817082A (en) * | 1996-11-08 | 1998-10-06 | Bracco Diagnostics Inc. | Medicament container closure with integral spike access means |
US5895383A (en) * | 1996-11-08 | 1999-04-20 | Bracco Diagnostics Inc. | Medicament container closure with recessed integral spike access means |
US6213994B1 (en) | 1997-09-25 | 2001-04-10 | Becton Dickinson France, S.A. | Method and apparatus for fixing a connector assembly onto a vial |
US6090093A (en) * | 1997-09-25 | 2000-07-18 | Becton Dickinson And Company | Connector assembly for a vial having a flexible collar |
US5925029A (en) * | 1997-09-25 | 1999-07-20 | Becton, Dickinson And Company | Method and apparatus for fixing a connector assembly onto a vial with a crimp cap |
US5989237A (en) | 1997-12-04 | 1999-11-23 | Baxter International Inc. | Sliding reconstitution device with seal |
US6003566A (en) | 1998-02-26 | 1999-12-21 | Becton Dickinson And Company | Vial transferset and method |
US6382442B1 (en) | 1998-04-20 | 2002-05-07 | Becton Dickinson And Company | Plastic closure for vials and other medical containers |
US6681946B1 (en) | 1998-02-26 | 2004-01-27 | Becton, Dickinson And Company | Resealable medical transfer set |
US6209738B1 (en) | 1998-04-20 | 2001-04-03 | Becton, Dickinson And Company | Transfer set for vials and medical containers |
US6904662B2 (en) * | 1998-04-20 | 2005-06-14 | Becton, Dickinson And Company | Method of sealing a cartridge or other medical container with a plastic closure |
US6957745B2 (en) * | 1998-04-20 | 2005-10-25 | Becton, Dickinson And Company | Transfer set |
US6378714B1 (en) | 1998-04-20 | 2002-04-30 | Becton Dickinson And Company | Transferset for vials and other medical containers |
US7358505B2 (en) | 1998-09-15 | 2008-04-15 | Baxter International Inc. | Apparatus for fabricating a reconstitution assembly |
US6022339A (en) | 1998-09-15 | 2000-02-08 | Baxter International Inc. | Sliding reconstitution device for a diluent container |
AR021220A1 (en) | 1998-09-15 | 2002-07-03 | Baxter Int | CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER. |
US7074216B2 (en) | 1998-09-15 | 2006-07-11 | Baxter International Inc. | Sliding reconstitution device for a diluent container |
US7425209B2 (en) | 1998-09-15 | 2008-09-16 | Baxter International Inc. | Sliding reconstitution device for a diluent container |
DE19847968A1 (en) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit. |
US6394987B1 (en) * | 1999-06-08 | 2002-05-28 | Tamara Marie Sandlin | Portable disinfectant apparatus |
US6551298B1 (en) * | 2000-11-21 | 2003-04-22 | Jack Y. Zhang | Controlled medicament security enclosure system |
EP1617888B1 (en) | 2003-04-23 | 2019-06-12 | Valeritas, Inc. | Hydraulically actuated pump for long duration medicament administration |
US6910573B2 (en) * | 2003-04-24 | 2005-06-28 | David M. Deans | Dual container bottle |
CN101415389A (en) * | 2003-10-02 | 2009-04-22 | 生物平衡公司 | Dried biotherapeutic composition, uses, and device and methods for administration thereof |
US7641851B2 (en) | 2003-12-23 | 2010-01-05 | Baxter International Inc. | Method and apparatus for validation of sterilization process |
US9089636B2 (en) | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US20060011660A1 (en) * | 2004-07-13 | 2006-01-19 | Sandlin Tamara M | Portable dispensing apparatus |
US7731678B2 (en) | 2004-10-13 | 2010-06-08 | Hyprotek, Inc. | Syringe devices and methods for mixing and administering medication |
WO2007056773A2 (en) * | 2005-11-09 | 2007-05-18 | Hyprotek, Inc. | Syringe devices, components of syringe devices, and methods of forming components and syringe devices |
WO2007115039A2 (en) | 2006-03-30 | 2007-10-11 | Valeritas, Llc | Multi-cartridge fluid delivery device |
ES2544556T3 (en) | 2006-05-25 | 2015-09-01 | Bayer Healthcare Llc | Reconstitution device |
US8002737B2 (en) | 2007-10-04 | 2011-08-23 | Hyprotek, Inc. | Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers |
US9522097B2 (en) | 2007-10-04 | 2016-12-20 | Hyprotek, Inc. | Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
US7905873B2 (en) * | 2008-07-03 | 2011-03-15 | Baxter International Inc. | Port assembly for use with needleless connector |
US8172823B2 (en) * | 2008-07-03 | 2012-05-08 | Baxter International Inc. | Port assembly for use with needleless connector |
US8062280B2 (en) * | 2008-08-19 | 2011-11-22 | Baxter Healthcare S.A. | Port assembly for use with needleless connector |
US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
US8394080B2 (en) * | 2009-05-14 | 2013-03-12 | Baxter International Inc. | Needleless connector with slider |
EP2432531B1 (en) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalation device and nebulizer |
AP3141A (en) | 2009-11-25 | 2015-02-28 | Boehringer Ingelheim Int | Nebulizer |
WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
BR112013004938B8 (en) * | 2010-09-02 | 2020-10-13 | Kraft Foods Group Brands Llc | containers for dispensing beverage concentrates |
EP2694220B1 (en) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
GB2485254C (en) * | 2011-08-22 | 2013-12-25 | Eulysis Uk Ltd | A container having a recessed closure for drying and storing one or more active agents |
SG192312A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
SG192310A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
SG11201404436XA (en) | 2012-02-02 | 2014-08-28 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling with a medical container |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
CN105878017A (en) * | 2012-07-06 | 2016-08-24 | 纳克斯梅德控股公司 | Redissolution method and redissolution device |
JP1526207S (en) | 2013-08-05 | 2015-06-15 | ||
ES2836977T3 (en) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizer |
EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
WO2015169429A2 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Container, indicator device, and nebulizer |
WO2015169430A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP6580070B2 (en) | 2014-05-07 | 2019-09-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Container, nebulizer, and use |
CN114044241B (en) * | 2021-12-08 | 2023-06-09 | 广西科健邦生物技术有限公司 | Pre-albumin determination kit with good stability |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653610A (en) * | 1950-10-28 | 1953-09-29 | Arthur E Smith | Dispensing closure |
US2695614A (en) * | 1952-12-10 | 1954-11-30 | Compule Corp | Plural-compartment admixing vial |
US2908274A (en) * | 1953-06-29 | 1959-10-13 | Abbott Lab | Closure |
US2813649A (en) * | 1955-06-30 | 1957-11-19 | Lipari Michael | Receptacles |
US3206080A (en) * | 1962-07-23 | 1965-09-14 | Abbott Lab | Dispensing assembly |
US3464414A (en) * | 1963-07-31 | 1969-09-02 | Upjohn Co | Mixing vial construction |
US3563415A (en) * | 1969-06-04 | 1971-02-16 | Multi Drop Adapter Corp | Multidrop adapter |
US3674028A (en) * | 1969-06-04 | 1972-07-04 | Ims Ltd | Multi-mix |
US4089432A (en) * | 1977-05-06 | 1978-05-16 | The Upjohn Company | Vial and closure |
US4234083A (en) * | 1979-11-13 | 1980-11-18 | Cohen Milton J | Mixing and filtering vial |
US4402420A (en) * | 1981-12-07 | 1983-09-06 | Extracorporeal Medical Specialties, Inc. | Dual function port cap |
US4515586A (en) * | 1982-11-30 | 1985-05-07 | Abbott Laboratories | Powder syringe mixing system |
IE57676B1 (en) * | 1984-03-19 | 1993-02-24 | Abbott Lab | Drug delivery system |
US4632267A (en) * | 1984-11-13 | 1986-12-30 | Baxter Travenol Laboratories, Inc. | Overmolded port closure |
IT1185850B (en) * | 1985-08-02 | 1987-11-18 | Zambon Spa | DROP TANK CAP FOR BOTTLES |
US4657534A (en) * | 1985-11-04 | 1987-04-14 | Alcon Laboratories, Inc. | Dual compartment, disposable, mixing and dispensing container |
US4871354A (en) * | 1986-07-24 | 1989-10-03 | The West Company | Wet-dry bag with lyphozation vial |
-
1989
- 1989-12-22 CA CA 2006582 patent/CA2006582A1/en not_active Abandoned
- 1989-12-27 EP EP19900900743 patent/EP0403626B1/en not_active Expired - Lifetime
- 1989-12-27 ES ES90900743T patent/ES2044548T3/en not_active Expired - Lifetime
- 1989-12-27 WO PCT/CH1989/000225 patent/WO1990007319A1/en active IP Right Grant
- 1989-12-27 DE DE90900743T patent/DE68909402T2/en not_active Expired - Lifetime
- 1989-12-27 JP JP50094490A patent/JPH0669475B2/en not_active Expired - Lifetime
- 1989-12-27 AT AT90900743T patent/ATE94749T1/en not_active IP Right Cessation
-
1993
- 1993-10-18 US US08/138,877 patent/US5533994A/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013006757A3 (en) * | 2011-07-06 | 2013-07-11 | Nexmed Holdings, Inc. | Reconstitution device |
EA029983B1 (en) * | 2011-07-06 | 2018-06-29 | Ферринг Интернешнл Сентер С.А. | Reconstitution device and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
DE68909402D1 (en) | 1993-10-28 |
WO1990007319A1 (en) | 1990-07-12 |
ES2044548T3 (en) | 1994-01-01 |
JPH03504569A (en) | 1991-10-09 |
ATE94749T1 (en) | 1993-10-15 |
EP0403626A1 (en) | 1990-12-27 |
US5533994A (en) | 1996-07-09 |
JPH0669475B2 (en) | 1994-09-07 |
CA2006582A1 (en) | 1990-06-27 |
DE68909402T2 (en) | 1994-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0403626B1 (en) | Storage and transfer bottle designed for storing two components of a medicamental substance | |
EP0406374B1 (en) | Storage and transfer bottle designed for storing a component of a medicamental substance | |
EP0453555B1 (en) | Storage bottle containing a constituent of a medicinal solution | |
EP1079789B1 (en) | Ampoule containing a liquid for medical purposes | |
EP0684846B1 (en) | Prefilled syringe for storing and dispensing a sterile liquid drug | |
EP0625917B1 (en) | Device for preparing a medicinal substance solution, suspension or emulsion | |
EP0717611B1 (en) | Syringe device for mixing two compounds | |
EP1226077B1 (en) | Ready-to-use connecting device | |
EP1006981B1 (en) | Connecting device, in particular between a receptacle with a stopper capable of being perforated and a syringe | |
WO1999036029A1 (en) | Sealed confinement device for connecting a container and means for delivering a substance | |
WO2002053086A1 (en) | Ampule for packaging and transferring a liquid or a powder for medical use | |
WO2002032372A1 (en) | Device for connection between a vessel and a container and ready-to-use assembly comprising same | |
WO1995032015A1 (en) | Device for the preparation of a solution, a suspension or an emulsion of a medicinal substance | |
FR2717086A1 (en) | Syringe system for mixing two compounds | |
WO1997020536A1 (en) | Device for preparing a medicinal solution reconstituted from two components | |
EP1034772B1 (en) | Device for transfering a substance contained in a vial to a pouch containing a solute | |
WO1998049994A1 (en) | Device for dissolving a freeze-dried product, contained in a disposable cartridge used in an injection device without needle | |
FR2767514A1 (en) | MIXER BOTTLE COMBINING TWO INSULATED COMPONENTS BEFORE THEY ARE COLLECTED AND INJECTED WITH A SYRINGE | |
EP1435893B1 (en) | Safety packaging for a bottle for medical use | |
FR2853830A1 (en) | Cap for transferring medication from a bottle to a solute pouch has two separate compartments and sealed cover for hollow needle | |
FR2715311A1 (en) | Syringe system for mixing two compounds | |
FR2714294A1 (en) | Syringe system for mixing two compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19900825 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE ES FR GB IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19920319 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE ES FR GB IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 94749 Country of ref document: AT Date of ref document: 19931015 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 68909402 Country of ref document: DE Date of ref document: 19931028 |
|
ITF | It: translation for a ep patent filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: BECTON DICKINSON FRANCE S.A. |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19931115 |
|
EPTA | Lu: last paid annual fee | ||
BECA | Be: change of holder's address |
Free format text: 930922 S.A. *BECTON DICKINSON FRANCE:11 RUE ARISTIDE BERGES, F-38800 LE PONT-DE-CLAIX |
|
BECH | Be: change of holder |
Free format text: 930922 S.A. *BECTON DICKINSON FRANCE |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2044548 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
NLS | Nl: assignments of ep-patents |
Owner name: BECTON DICKINSON FRANCE S.A. TE LE PONT-DE-CLAIX, |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
ITPR | It: changes in ownership of a european patent |
Owner name: CESSIONE;BECTON DICKINSON FRANCE S.A. |
|
EAL | Se: european patent in force in sweden |
Ref document number: 90900743.7 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20081223 Year of fee payment: 20 Ref country code: CH Payment date: 20081229 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20081203 Year of fee payment: 20 Ref country code: ES Payment date: 20081226 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20090106 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20090202 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20081229 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20090202 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20081229 Year of fee payment: 20 Ref country code: IT Payment date: 20081224 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: CABINET ROLAND NITHARDT CONSEILS EN PROPRIETE INDUSTRIELLE S.A.;Y-PARC RUE GALILEE;1400 YVERDON-LES-BAINS (CH) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20081217 Year of fee payment: 20 |
|
BE20 | Be: patent expired |
Owner name: S.A. *BECTON DICKINSON FRANCE Effective date: 20091227 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20091226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20091227 |
|
NLV7 | Nl: ceased due to reaching the maximum lifetime of a patent |
Effective date: 20091227 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20091228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20091226 Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20091228 |